Koers 1933 Industries Inc Toronto S.E.
Aandelen
VPR
CA74840V1004
Farmaceutische producten
Omzet 2022 | 12,54 mln. 9,18 mln. 8,46 mln. | Omzet 2023 | 18,27 mln. 13,38 mln. 12,34 mln. | Marktkapitalisatie | 6,92 mln. 5,07 mln. 4,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -17 mln. -12,45 mln. -11,48 mln. | Nettowinst (verlies) 2023 | -13 mln. -9,52 mln. -8,78 mln. | EV/omzet 2022 | 2,28 x |
Nettoschuld 2022 | 17,32 mln. 12,68 mln. 11,69 mln. | Nettoschuld 2023 | 16,48 mln. 12,07 mln. 11,12 mln. | EV/omzet 2023 | 1,28 x |
K/w-verhouding 2022 |
-0,63
x | K/w-verhouding 2023 |
-0,51
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 91,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Rosen
CEO | Chief Executive Officer | 60 | 15-06-20 |
Ester Vigil
PSD | President | - | - |
Brian Farrell
DFI | Director of Finance/CFO | - | 15-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 23-11-15 |
Brian Farrell
DFI | Director of Finance/CFO | - | 15-03-18 |
Curtis Floyd
BRD | Director/Board Member | - | 21-06-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,40% | 4,15 mld. | |
+131,39% | 2,3 mld. | |
+185,71% | 99,91 mln. |